These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38145078)

  • 21. Characteristics of non-carbapenemase producing carbapenem-resistant Klebsiella pneumoniae from a tertiary hospital in China.
    Ruan Y; Li M; Wang D; Duan J; Zhang H; Zhou Y
    J Infect Dev Ctries; 2024 Jan; 18(1):106-115. PubMed ID: 38377097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs].
    Perçin D; Colakoğlu S; Durmaz S; Ekincioğlu P
    Mikrobiyol Bul; 2012 Oct; 46(4):546-52. PubMed ID: 23188568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Epidemiology, Microbial Virulence, and Resistance of Carbapenem-Resistant
    Peng C; Feng DH; Zhan Y; Wang Q; Chen DQ; Xu Z; Yang L
    Microb Drug Resist; 2022 Jun; 28(6):698-709. PubMed ID: 35639427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant
    Shortridge D; Kantro V; Castanheira M
    Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) and the Distribution of Class 1 Integron in Their Strains Isolated from a Hospital in Central China.
    Ou Q; Li W; Li B; Yu C
    Chin Med Sci J; 2017 Jun; 32(2):107-2. PubMed ID: 28693691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
    Johnson JK; Robinson GL; Pineles LL; Ajao AO; Zhao L; Albrecht JS; Harris AD; Thom KA; Furuno JP
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country.
    Aiesh BM; Maali Y; Qandeel F; Omarya S; Taha SA; Sholi S; Sabateen A; Taha AA; Zyoud SH
    BMC Infect Dis; 2023 Oct; 23(1):644. PubMed ID: 37784023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The Epidemiology of Carbapenemases in Escherichia coli and Klebsiella pneumoniae Isolated in 2019 in Turkey].
    Süzük Yıldız S; Şimşek H; Bakkaloğlu Z; Numanoğlu Çevik Y; Hekimoğlu CH; Kılıç S; Alp Meşe E;
    Mikrobiyol Bul; 2021 Jan; 55(1):1-16. PubMed ID: 33590977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes and Trends of Drug Resistance of Pathogenic Bacteria in Blood Samples of a Tertiary-Level Teaching Hospital from 2016 to 2020].
    Deng J; Kang M; Xie Y; Ma Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):688-695. PubMed ID: 35871742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
    Zornic S; Petrovic I; Lukovic B
    Acta Microbiol Immunol Hung; 2023 Sep; 70(3):187-192. PubMed ID: 37535440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surveillance of bacterial resistance in children aged 0-14 years from 2018 to 2022].
    China Antimicrobial Resistance Surveillance System
    Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):1001-1010. PubMed ID: 37855078
    [No Abstract]   [Full Text] [Related]  

  • 32. Increasing Frequency of New Delhi Metallo-beta-Lactamase and Klebsiella pneumoniae Carbapenemase Resistant Genes in a Set of Population of Karachi.
    Afridi FI; Sani AI; Khan R; Baig S; Zaidi SAA; Jamal Q
    J Coll Physicians Surg Pak; 2023 Jan; 33(1):59-65. PubMed ID: 36597237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].
    Hoşbul T; Aydoğan CN; Kaya S; Bedir O; Gümral R; Albay A
    Mikrobiyol Bul; 2022 Apr; 56(2):218-229. PubMed ID: 35477226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and molecular epidemiology of carbapenem-resistant
    Ye L; Zhang LY; Zhao Y; Gu B; Wu Z; Peng YZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Aug; 24(8):881-886. PubMed ID: 36036126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
    Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
    Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The first nationwide surveillance of carbapenem-resistant Enterobacterales in the United Arab Emirates - increased association of Klebsiella pneumoniae CC14 clone with Emirati patients.
    Sonnevend Á; Abdulrazzaq N; Ghazawi A; Thomsen J; Bharathan G; Makszin L; Rizvi TA; Pál T;
    Int J Infect Dis; 2022 Jul; 120():103-112. PubMed ID: 35470020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic Insights Into the Mechanism of Carbapenem Resistance Dissemination in Enterobacterales From a Tertiary Public Heath Setting in South Asia.
    Farzana R; Jones LS; Rahman MA; Sands K; van Tonder AJ; Portal E; Criollo JM; Parkhill J; Guest MF; Watkins WJ; Pervin M; Boostrom I; Hassan B; Mathias J; Kalam MA; Walsh TR
    Clin Infect Dis; 2023 Jan; 76(1):119-133. PubMed ID: 35412593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency Determination of Carbapenem-Resistant Klebsiella Pneumoniae (CRKP) Isolated from hospitals in Isfahan of Iran and Evaluation of Synergistic Effect of Colistin and Meropenem on them.
    Gheitani L; Fazeli H; Moghim S; Nasr Isfahani B
    Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):70-74. PubMed ID: 29412797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of ertapenem and other carbapenems against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae clinical isolates in a tertiary care center in Turkey.
    Kiremitci A; Dinleyici EC; Erben N; Durmaz G; Yargic ZA; Aybey AD; Usluer G
    Expert Opin Pharmacother; 2008 Jun; 9(9):1441-9. PubMed ID: 18518776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
    Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
    J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.